Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The anticonvulsant hypersensitivity syndrome

S E Handfield-Jones1, R E Jenkins, S J Whittaker

  • 1St John's Dermatology Centre, St Thomas' Hospital, London, U.K.

The British Journal of Dermatology
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.

The British journal of dermatology·2018
Same author

Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response.

Journal of proteomics·2018
Same author

Neutrophilic urticarial dermatosis: a novel association with poststreptococcal rheumatic disease.

Clinical and experimental dermatology·2017
Same author

Diffuse large B-cell lymphoma developing in erythrodermic cutaneous T-cell lymphoma: a case series.

The British journal of dermatology·2017
Same author

Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.

Letters in applied microbiology·2016
Same author

Detection of drug-responsive B lymphocytes and antidrug IgG in patients with β-lactam hypersensitivity.

Allergy·2016
Same journal

Shallow Cuts, Deeper Issues: The Primacy of Deep Margins in Cutaneous Squamous Cell Carcinoma.

The British journal of dermatology·2026
Same journal

Management Patterns and Repigmentation Outcomes in Pediatric Segmental Versus Non-segmental Vitiligo: A Single-center Retrospective Study (2015-2024).

The British journal of dermatology·2026
Same journal

Quality-of-Life Measurement in Migrants and Other Vulnerable Groups: Experience with Skindex-16 in Malta and Lebanon.

The British journal of dermatology·2026
Same journal

Does loss of chromosome Y in blood contribute to the sex disparity of dermatitis and eczema at older ages?

The British journal of dermatology·2026
Same journal

Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation.

The British journal of dermatology·2026
Same journal

Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials.

The British journal of dermatology·2026
See all related articles

Anticonvulsants can trigger a severe hypersensitivity syndrome affecting multiple organ systems. This reaction, characterized by fever and rash, can recur with different anticonvulsant medications.

Area of Science:

  • Pharmacology
  • Toxicology
  • Immunology

Background:

  • Anticonvulsant medications are widely prescribed for seizure disorders.
  • Hypersensitivity reactions are a known, though often under-recognized, adverse effect of anticonvulsants.
  • These reactions can involve multiple organ systems and pose significant health risks.

Observation:

  • The study presents three cases of anticonvulsant hypersensitivity syndrome.
  • Typical symptoms include fever, mucocutaneous eruptions, lymphadenopathy, and hepatitis.
  • Less common complications of this syndrome were also observed.

Findings:

  • Anticonvulsant hypersensitivity syndrome is a multisystemic adverse drug reaction.
  • Cross-reactivity between different anticonvulsants is a significant clinical challenge.

Related Experiment Videos

  • The syndrome can manifest with both typical and atypical clinical features.

    • Implications:

    • Early recognition and diagnosis of anticonvulsant hypersensitivity are crucial for patient safety.
    • Awareness of cross-reactivity is essential for managing subsequent anticonvulsant therapy.
    • This syndrome represents a serious, potentially life-threatening condition requiring careful clinical management.